The global Next-Generation Sequencing (NGS) market is projected to grow from USD 13.81 billion in 2026 to USD 27.14 billion by 2031, registering a robust CAGR of 14.5% during the forecast period.
The market growth is primarily driven by the increasing demand for NGS-based diagnostics and personalized medicine, along with continuous advancements in sequencing platforms that improve speed, accuracy, and cost efficiency. However, high initial investment costs for sequencing infrastructure remain a key challenge for market expansion.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=546
In 2025, the products segment dominated the market due to recurring demand for consumables and the high cost of sequencing instruments. By technology, sequencing by synthesis (SBS) held the largest share, owing to its widespread application across genomics, transcriptomics, and epigenomics research.
Among services, sequencing services led the market, supported by large-scale genomics initiatives by governments and private organizations. In terms of application, diagnostics accounted for the largest share, driven by declining sequencing costs and increased adoption in clinical settings.
Academic and research institutes emerged as the leading end users, benefiting from flexible NGS workflows and early adoption of advanced techniques such as single-cell sequencing and spatial transcriptomics.
Regionally, North America held the largest market share in 2025, supported by advanced healthcare infrastructure and strong research capabilities. Meanwhile, the Asia Pacific region is expected to witness the fastest growth due to expanding genomics programs and increasing collaborations across the life sciences sector.
Key players operating in the NGS market include Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, QIAGEN, Agilent Technologies, Inc., and Oxford Nanopore Technologies plc, among others
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
